On July 31, 2026, HRSA announced a revised version of the 340B Rebate Model Pilot Program would take effect on January 1, 2027. The new rebate model represents the first time since 340B’s inception that the core payment mechanism itself has shifted, rather than the boundaries around it.
Covered entities have always received their 340B savings at the point of purchase. But now, they must purchase eligible drugs at full price and recover savings through a rebate after claim submission and validation. This shift in payment structure introduces new operational requirements that many organizations have never managed at scale. And as a result, every eligible claim will matter more than ever.
Historically, the 340B discount used to apply itself at the point of sale. But that will not happen automatically anymore. Covered entities must complete a series of steps, including: accurately identifying, tracking, reporting, and reconciling every eligible transaction. Any error at one of these steps stops an organization from getting its rebate.
Success hinges on whether covered entities can:
Without those capabilities, missed claims can become missed revenue.
Today's 340B workflow largely focuses on determining whether a claim is eligible for 340B pricing. Under the rebate model, that determination becomes just the beginning.
Manufacturers must independently validate eligibility before issuing payment, creating entirely new operational workflows centered around claim-level reporting, payment reconciliation, documentation, and dispute management.
Organizations should begin asking:
For more than three decades, covered entities realized their 340B savings immediately through discounted purchasing. Under the rebate model, those savings become delayed until manufacturers validate claims and issue payment.
That shift changes more than operations.
Organizations will need to understand:
340B programs may find themselves managing financial processes they have never needed before.
The rebate model also introduces a new level of interaction between covered entities and manufacturers. Instead of receiving an automatic upfront discount, organizations should expect ongoing communication related to rebate submissions, payment reconciliation, and claim validation.
As manufacturer participation expands, covered entities may encounter different reporting expectations, payment timelines, reconciliation processes, and dispute resolution requirements.
Organizations relying on manual processes may find it increasingly difficult to manage these additional administrative responsibilities at scale.
Organizations cannot afford to wait until every manufacturer announces participation in the rebate model, because it compresses their implementation timeline. They need time to validate processes before the first rebate claims are due. Therefore, covered entities must start evaluating their workflows, reporting processes, internal controls, and technology now.
To prepare, organizations should:
January 1 is not the finish line. It is the beginning of an entirely new reimbursement process.
The organizations that begin preparing today will have time to validate workflows, strengthen internal controls, and implement the technology needed to support accurate rebate reporting.
Those that wait risk compressing months of operational preparation into just a few short weeks while managing live rebate submissions.
The rebate model rewards preparation, accuracy, and visibility. The window to prepare has officially opened. The question is no longer whether the rebate model is coming, it's whether your organization will be ready when it arrives.